Blue Cell Therapeutics appoints leading cell therapy executive Miguel Forte MD, PhD, to its Board of Directors
- Miguel Forte, current President of the International Society for Cell & Gene Therapy (ISCT), joins Blue Cell as a Non-Executive Director
- Highly experienced executive with deep scientific expertise, who has helped lead numerous private and public cell therapy biotechs, establishing corporate structures and raising funds
- Appointment comes as Blue Cell advances its groundbreaking “off-the-shelf” allogeneic stem cell therapies for severe erectile dysfunction (ED) and pulmonary arterial hypertension (PAH)
Copenhagen, Denmark, 13 November 2025 – Blue Cell Therapeutics, a biotech developing “off-the-shelf” allogeneic stem cell therapies for diseases where angiogenesis and nerve regeneration are beneficial, today announces the appointment of Miguel Forte MD, PhD, to its Board of Directors.
